108 related articles for article (PubMed ID: 24266691)
41. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Fan X; Chen J; Shen Q
Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
[TBL] [Abstract][Full Text] [Related]
42. Computer-based formulation design and optimization using Hansen solubility parameters to enhance the delivery of ibuprofen through the skin.
Jameel BM; Huynh A; Chadha A; Pandey S; Duncan J; Chandler M; Baki G
Int J Pharm; 2019 Oct; 569():118549. PubMed ID: 31394188
[TBL] [Abstract][Full Text] [Related]
43. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
44. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
45. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
46. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
[TBL] [Abstract][Full Text] [Related]
47. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
Akram M; Naqvi SB; Khan A
Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
[TBL] [Abstract][Full Text] [Related]
48. Submicron polymeric particles prepared by vibrational spray-drying: Semisolid formulation and skin penetration/permeation studies.
Beber TC; Andrade DF; Kann B; Fontana MC; Coradini K; Windbergs M; Beck RC
Eur J Pharm Biopharm; 2014 Nov; 88(3):602-13. PubMed ID: 25078859
[TBL] [Abstract][Full Text] [Related]
49. [Preparation of diazepam transdermal gel and its bioavailability].
Xu Q; Zan YP; Gao CH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):441-4, 463. PubMed ID: 22927081
[TBL] [Abstract][Full Text] [Related]
50. Penetration of crystalline powder particles into excised human skin membranes and model gels from a supersonic powder injector.
Lahm K; Lee G
J Pharm Sci; 2006 Jul; 95(7):1511-26. PubMed ID: 16724324
[TBL] [Abstract][Full Text] [Related]
51. [Effects of penetration enhancers on in vitro percutaneous absorption and amount retained in skin of paeonol, dictamnine, fraxinellone and glycyrrhetinic acid in Liangfu cream].
Wang S; Zhu W; Ou S; Guan Y; Chen L; Yang M
Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1778-82. PubMed ID: 19894505
[TBL] [Abstract][Full Text] [Related]
52. Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsion-gelation method.
Malakar J; Nayak AK; Pal D
Int J Biol Macromol; 2012 Jan; 50(1):138-47. PubMed ID: 22020191
[TBL] [Abstract][Full Text] [Related]
53. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
54. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants.
Liu CH; Chang FY; Hung DK
Colloids Surf B Biointerfaces; 2011 Jan; 82(1):63-70. PubMed ID: 20828994
[TBL] [Abstract][Full Text] [Related]
55. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
[TBL] [Abstract][Full Text] [Related]
56. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
57. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
[TBL] [Abstract][Full Text] [Related]
58. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
59. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
Prasanthi D; Lakshmi PK
Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
[TBL] [Abstract][Full Text] [Related]
60. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
